United States · Bill · HR
H.R. 5092 (103rd)
Biomaterials Access Assurance Act of 1994
Introduced
23 September 1994
Last action
—
Status
Referred to the Subcommittee on Commerce, Consumer Protection and Competitiveness.
Sponsors
—
Subjects
Discovery layer
Source updated
26 August 2025
Summary
Biomaterials Access Assurance Act of 1994 - Declares that this Act applies to any civil action brought in either State or Federal court against a manufacturer, seller, or biomaterials supplier, or against a licensor of such suppliers for harm caused by an implant. Prescribes procedural guidelines and the burden of proof for actions against biomaterials suppliers for harm caused by an implant. Precludes such actions, except as provided under this Act, against a person who has neither registered with the Secretary of Health and Human Services nor included the implant on a list of devices filed pursuant to the Federal Food, Drug, and Cosmetic Act.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in House (text)
Introduced in House (text)
Introduced in House · EN · 23 September 1994
Introduced in House (PDF)
Introduced in House · EN · 23 September 1994
Introduced in House
summary · EN · 23 September 1994
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/103rd-congress/house-bill/5092
- Open data entity: https://api.congress.gov/v3/bill/103/hr/5092